Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $8.43 ($168,652)
  4. 4 Planned sale CHIEF MEDICAL OFFICER sold 12,000 shares at an average $15.94 ($191,339)
  5. 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $15.92 ($318,334)
  6. 4 Planned sale PRESIDENT & CSO sold 50,000 shares at $14.20 ($710,195)
  7. 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $11.15 ($223,036)
  8. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 4,400 shares at $11.31 ($49,771)
  9. 4 Grant or award SVP, FINANCE AND CAO acquired 15,000 shares (grant or award)
  10. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
  11. 4 Grant or award CHIEF MEDICAL OFFICER acquired 30,000 shares (grant or award)
  12. 4 Grant or award PRESIDENT & CSO acquired 30,000 shares (grant or award)
  13. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 60,000 shares (grant or award)
  14. 4 Open-market sale SVP, Finance and CAO sold 2,717 shares at $13.60 ($36,957)
  15. 4 Open-market sale SVP, Finance and CAO sold 1,631 shares at $15.04 ($24,530)
  16. 4 Open-market sale Chief Medical Officer sold 3,128 shares at $15.04 ($47,045)
  17. 4 Open-market sale Chief Financial Officer sold 1,893 shares at $15.04 ($28,471)
  18. 4 Open-market sale President & CSO sold 7,179 shares at $15.04 ($107,972)
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)

Page 5 of 11 · 213 filings